| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 3,298.64 | 2,884.16 | 2,189.88 | 1,892.00 |
| Sale of Products | 3,251.81 | 2,852.64 | 2,158.74 | 1,839.21 |
| Sale of Services | 11.40 | 2.79 | 3.66 | 9.87 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 2,017.47 | 1,911.75 | 1,281.76 | 633.65 |
| Property, Plant and Equipments | 546.83 | 503.39 | 519.47 | 519.41 |
| Right-of-Use Assets | 24.73 | 28.62 | 33.44 | 24.68 |
| Intangible Assets | 1,432.84 | 1,369.00 | 724.08 | 89.56 |
| Market Cap (Rs in Crs) | 24,535.51 | |
|---|---|---|
| P/E | 39.03 | |
| Book Value (Rs) | 202.81 | |
| Div (%) | 1225 | |
| Market Lot | 1 | |
| EPS (TTM) | 40.38 | |
|---|---|---|
| Price/Book | 7.77 | |
| Div Yield.(%) | 0.77 | |
| Face value (RS) | 1 | |
| Deliverables (%) | 54.26 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 4,28,725.17 | 1,786.85 | 1,804.50 | -0.98 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,59,525.38 | 6,009.20 | 6,215.55 | -3.32 | 6,448.75 - 3,725.55 |
| Cipla Ltd | 1,23,201.99 | 1,525.50 | 1,551.30 | -1.66 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,09,514.33 | 3,235.95 | 3,324.25 | -2.66 | 3,589.95 - 2,513.05 |
| Mankind Pharma ... | 1,05,275.60 | 2,551.65 | 2,602.80 | -1.97 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 2,94,95,581 | 18.95 |
| Total Institutions | 2,91,39,954 | 18.72 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 7,72,298 | 0.50 |
| Total Promoters | 7,44,81,519 | 47.84 |
| Total Public & others | 21787856 | 14.00 |
| Total | 15,56,77,208 | 100 |
